2 minute read - 11th March 2025
Almac opens new £65m manufacturing facility in Craigavon
Almac Group has opened a new £65m commercial manufacturing facility for Almac Pharma Services at its global headquarters in Craigavon, Northern Ireland.
The new 100,000 sq ft facility enhances existing capabilities in the commercial manufacture of oral dose treatments for a variety of therapeutic areas. The high-specification production suites are fully equipped with the latest in pharmaceutical manufacturing technology and include an extension to current production scales of potent and highly potent drug products.
Construction of the building was completed in late 2024, and following the successful completion of validation activities, the manufacture of GMP batches will commence next week (18 March) in the regulatory-approved facility. This centre of excellence has been designed with flexibility and a wide range of uses in mind. It includes opportunities for partner companies to install custom and/or dedicated technology tailored to their individual and emerging pipeline needs.
Almac Group has opened a new, state-of-the-art, £65m commercial manufacturing facility in Craigavon, Northern Ireland / Picture: Almac Group
Never miss the latest manufacturing news by signing up to our newsletter here
John McQuaid, president and managing director of Almac Pharma Services, said: “We are thrilled to officially open our new commercial manufacturing facility at our global headquarters site. This investment underscores our commitment to supporting our client’s growing needs with the highest level of service and expertise. The new facility not only expands our range of capabilities but also reinforces our position as an industry leader in pharmaceutical development and commercial manufacturing with an ability to tailor our services to suit individual products. It also demonstrates our commitment to working in true partnership with our clients as we support them in bringing important new therapies to the patients we serve.”
Almac Group added that the £65m investment in Craigavon marks a significant milestone in its ongoing global expansion programme. Almac initially committed £250m in capital investment and a growth of 1,800 new jobs across the Group globally in 2022. Since then, the Group has increased its projected investment figure to over £400m.
